Early 1990'sDr. Kichul Cha recognized BIA devices were inaccurate, making them useless to the medical industry.
1996InBody was founded in South Korea. Products feature direct segmental multi-frequency bioelectrical impedance analysis (DSM-BIA) and an eight-point tactile electrode system to measure an individual’s body composition without the use of empirical data.
2000InBody established its first overseas subsidiary in Beverly Hills, California. InBody technology is FDA approved and results have been validated by research.
2009GE Healthcare Strategic Business Partnership
2012InBody moved its corporate office from Beverly Hills to Cerritos, California.
2013The InBody 570, capable of measuring segmental fat analysis including visceral fat level, is released.
2014The InBody 770, a new research-grade body composition analyzer is launched and the InBody 570 wins the Red Dot Design Award.
2015iF DESIGN AWARD is given to the InBody 770.
InBody receives the 2015 Foreign Direct Investment Award from the Los Angeles Chamber of Commerce during World Trade Week.
InBody BAND and InLab win CES 2015 Innovation Award for wearable technologies.
InBody unveiled the InBody BAND, the world’s first wearable body composition device.
2016Lookin’BodyWeb, a cloud-based data software is launched.
The InBody PUSH, a handheld, portable stadiometer is released for the first time in the United States.
The InBody 270, designed specifically for professionals who need to analyze body composition on-the-go, goes on sale.
2017InBody releases the InBody BAND 2, a second-generation wearable body composition device.
The BAND 2 features EZTrainingTM, which automatically tracks exercises.
2019The InBody BPBIO 320S, is launched in April.
The InBody H20N, is launced in May.